News

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
Lupin Limited has received approval from the United States Food and Drug Administration for its Abbreviated New Drug ...
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...
Mumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) ...
While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...
Eight weeks. That’s how long it takes, on average, for the pounds to begin creeping back after someone stops taking the world ...
GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...
A new study published by Cleveland Clinic researchers in Diabetes, Obesity and Metabolism investigating the genetic ...
Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for ...
Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...
GLP-1 receptor agonists such as semaglutide and liraglutide promote significant weight loss and improved glycemic control, ...
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...